BOUT
Innovator IBD Breakout Opportunities ETF [BOUT] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BOUT Stock Summary
Top BOUT Correlated Resources
BOUT
Top 10 Correlated ETFs
BOUT
Top 10 Correlated Stocks
BOUT
In the News
BOUT Financial details
Company Rating
-
Market Cap
14.34M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.44
Dividend %
1.36%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
4.63%
SMA50
19.26%
SMA100
24.27%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
28.58-36.58
52W High
+29.28%
52W Low
+66.21%
RSI
59.22
Rel Volume
0.14
Avg Volume
2.17K
Volume
303
Perf Week
3.81%
Perf Month
8.16%
Perf Quarter
26.09%
Perf Half Y
24.51%
-
-
-
-
Beta
0.99
-
-
Volatility
0.54%, 1.21%
Prev Close
-0.39%
Price
46.54
Change
0.19%
BOUT Financial Performance
BOUT Frequently Asked Questions
What is Innovator IBD Breakout Opportunities ETF stock symbol ?
Innovator IBD Breakout Opportunities ETF is a US stock and trading under the symbol BOUT
What is Innovator IBD Breakout Opportunities ETF stock quote today ?
Innovator IBD Breakout Opportunities ETF stock price is $46.54 today.
Is Innovator IBD Breakout Opportunities ETF stock public?
Yes, Innovator IBD Breakout Opportunities ETF is a publicly traded company.
Company Profile
- Volume Average 2.17K
- Market Capitalization 14.34M
- Headquarters US
- IPO Date 2018-09-13
The fund will normally invest at least 80% of its net assets (including investment borrowings) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock's recent "resistance level," with consideration for various market conditions. The fund is non-diversified.
